BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, Falck-Ytter YT, Dellon ES; AGA Institute. Electronic address: clinicalpractice@gastro.org., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Electronic address: drdanawallace@gmail.com., AGA Institute., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters. Ann Allergy Asthma Immunol 2020;124:424-440.e17. [PMID: 32336463 DOI: 10.1016/j.anai.2020.03.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Oshima T, Huang X, Tomita T, Fukui H, Miwa H. Esophageal Mucosal Permeability as a Surrogate Measure of Cure in Eosinophilic Esophagitis. JCM 2022;11:4246. [DOI: 10.3390/jcm11144246] [Reference Citation Analysis]
2 Strauss AL, Falk GW. Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet. Curr Opin Gastroenterol 2022;38:395-401. [PMID: 35762699 DOI: 10.1097/MOG.0000000000000842] [Reference Citation Analysis]
3 Lucendo AJ. Drug treatment strategies for eosinophilic esophagitis in adults. Expert Opin Pharmacother 2022;:1-14. [PMID: 35379069 DOI: 10.1080/14656566.2022.2060077] [Reference Citation Analysis]
4 Dellon ES, Lucendo AJ, Schlag C, Schoepfer AM, Falk GW, Eagle G, Nezamis J, Comer GM, Knoop K, Hirano I. Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00139-2. [PMID: 35181572 DOI: 10.1016/j.cgh.2022.02.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Schreiner P, Safroneeva E, Schoepfer A, Greuter T, Biedermann L, Schlag C, Labenz J, Auth MKH, Bredenoord AJ, Chang JW, Bonis PA, Rothenberg ME, Collins MH, Hirano I, Gupta SK, Katzka DA, Dellon ES, Straumann A, Furuta GT, Gonsalves N. Management of eosinophilic esophagitis associated food impaction in Europe and the United States. Dis Esophagus 2022:doac003. [PMID: 35088073 DOI: 10.1093/dote/doac003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yousef E, Korotkaya Y, Simpson AB. Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non-tertiary care private practice setup. Allergy Asthma Proc 2022;43:5-11. [PMID: 34983704 DOI: 10.2500/aap.2022.43.210084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Barni S, Arasi S, Mastrorilli C, Pecoraro L, Giovannini M, Mori F, Liotti L, Saretta F, Castagnoli R, Caminiti L, Cianferoni A, Novembre E. Pediatric eosinophilic esophagitis: a review for the clinician. Ital J Pediatr 2021;47:230. [PMID: 34809686 DOI: 10.1186/s13052-021-01178-2] [Reference Citation Analysis]
8 Kanikowska A, Hryhorowicz S, Rychter AM, Kucharski MA, Zawada A, Iwanik K, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. Immunogenetic, Molecular and Microbiotic Determinants of Eosinophilic Esophagitis and Clinical Practice-A New Perspective of an Old Disease. Int J Mol Sci 2021;22:10830. [PMID: 34639170 DOI: 10.3390/ijms221910830] [Reference Citation Analysis]
9 Eke R, Dellon ES. Hospitalization trends and determinants of inpatient costs for eosinophilic esophagitis patients in the United States: results from the Nationwide Inpatient Sample analysis. Ann Gastroenterol 2021;34:643-50. [PMID: 34475734 DOI: 10.20524/aog.2021.0638] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Chehade M, Aceves SS. Treatment of Eosinophilic Esophagitis: Diet or Medication? The Journal of Allergy and Clinical Immunology: In Practice 2021;9:3249-56. [DOI: 10.1016/j.jaip.2021.07.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chu DK, Spergel JM, Vickery BP. Management of Eosinophilic Esophagitis During Oral Immunotherapy. J Allergy Clin Immunol Pract 2021;9:3282-7. [PMID: 34325036 DOI: 10.1016/j.jaip.2021.07.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fiocchi A, Vickery BP, Wood RA. The use of biologics in food allergy. Clin Exp Allergy 2021;51:1006-18. [PMID: 33966304 DOI: 10.1111/cea.13897] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
13 Greenberg S, Chang NC, Corder SR, Reed CC, Eluri S, Dellon ES. Dilation-predominant approach versus routine care in patients with difficult-to-treat eosinophilic esophagitis: a retrospective comparison. Endoscopy 2021. [PMID: 33910259 DOI: 10.1055/a-1493-5627] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fabian E, Gröchenig HP, Bauer PK, Eherer AJ, Gugatschka M, Binder L, Langner C, Fickert P, Krejs GJ. Clinical-Pathological Conference Series from the Medical University of Graz : Case No 171: A 37-year-old engineer with bolus hold-up (esophageal food impaction). Wien Klin Wochenschr 2020;132:551-9. [PMID: 32601726 DOI: 10.1007/s00508-020-01694-x] [Reference Citation Analysis]
15 Onyimba F, Crowe SE, Johnson S, Leung J. Food Allergies and Intolerances: A Clinical Approach to the Diagnosis and Management of Adverse Reactions to Food. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00075-6. [PMID: 33493695 DOI: 10.1016/j.cgh.2021.01.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
16 Arsiè E, Cantù P, Penagini R. The role of endoscopy in eosinophilic esophagitis: from diagnosis to therapy. Minerva Gastroenterol (Torino) 2022;68:9-22. [PMID: 33267563 DOI: 10.23736/S2724-5985.20.02786-5] [Reference Citation Analysis]
17 Attwood S, Epstein J. Eosinophilic oesophagitis: recent advances and practical management. Frontline Gastroenterol 2021;12:644-9. [DOI: 10.1136/flgastro-2019-101313] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Puthanmadhom Narayanan S, Linden DR, Peters SA, Desai A, Kuwelker S, O'Brien D, Smyrk TJ, Graham RP, Grover M, Bharucha AE. Duodenal mucosal secretory disturbances in functional dyspepsia. Neurogastroenterol Motil 2021;33:e13955. [PMID: 32776463 DOI: 10.1111/nmo.13955] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
19 Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, Wang K, Greenhawt M, Falck-Ytter YT; AGA Institute Clinical Guidelines Committee., Joint Task Force on Allergy-Immunology Practice Parameters. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Ann Allergy Asthma Immunol 2020;124:416-23. [PMID: 32336462 DOI: 10.1016/j.anai.2020.03.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
20 Spergel JM, Aceves SS, Greenhawt M. Challenges with the technical review of eosinophilic esophagitis: discussion points for the practicing allergist. Ann Allergy Asthma Immunol 2020;124:411-3. [PMID: 32336460 DOI: 10.1016/j.anai.2020.03.011] [Reference Citation Analysis]
21 Hirano I, Furuta GT. Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. Gastroenterology 2020;158:840-51. [PMID: 31836530 DOI: 10.1053/j.gastro.2019.09.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]